Perturbation of the preterm human immune system in early life

Benjamin A Fensterheim1,2, Michelle L McKeague2,3, Divij Mathew2,3

  • 1Department of Pediatrics, Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

JCI Insight
|April 21, 2026
PubMed

Insights

Severe bronchopulmonary dysplasia (BPD) and infections uniquely alter neonatal immune development in preterm infants. These distinct immune signatures provide insights into immune pathways and potential interventions for premature babies.

Area of Science:

  • Neonatal immunology
  • Immunology
  • Pediatric research

Background:

  • Inflammatory complications are frequent in preterm infants.
  • Their impact on neonatal immune development is not well understood.

Purpose of the Study:

  • To investigate distinct immune signatures of severe bronchopulmonary dysplasia (BPD) and systemic infections in preterm infants.
  • To track changes in immune composition over time.

Main Methods:

  • Longitudinal high-dimensional immune profiling of residual whole blood.
  • Samples collected every two weeks from 38 preterm infants and at birth from 10 term infants.

Main Results:

  • Severe BPD associated with increased Th17 CD4+ T cells, neutrophils, and Th17 cytokines compared to moderate BPD.
  • Systemic infections triggered robust CD8+, CD4+, and γδ T cell responses with persistent changes in preterm infants.

Conclusions:

  • Different preterm comorbidities imprint the neonatal immune system distinctly.
  • Longitudinal immune profiling can reveal connections between clinical complications and immune pathways, identifying potential intervention targets.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
65.4K
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
58
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
58
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.3K
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
136